Core Viewpoint - Momentum investing focuses on "buying high and selling higher," contrasting with traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Characteristics - Momentum investing can be risky as stocks may lose momentum when their valuations exceed future growth potential [2] - Investing in bargain stocks with recent price momentum may be a safer approach [3] Group 2: Select Medical (SEM) Analysis - Select Medical (SEM) has shown a four-week price change of 11.9%, indicating strong investor interest [4] - SEM has gained 19.2% over the past 12 weeks, with a beta of 1.28, suggesting it moves 28% higher than the market [5] - SEM has a Momentum Score of B, indicating a favorable time to invest [6] Group 3: Earnings Estimates and Valuation - An upward trend in earnings estimate revisions has contributed to SEM's Zacks Rank 2 (Buy), which is associated with strong momentum effects [7] - SEM is trading at a Price-to-Sales ratio of 0.34, indicating it is relatively cheap at present [7] Group 4: Additional Investment Opportunities - Other stocks also meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, suggesting further investment opportunities [8] - Zacks offers over 45 Premium Screens to assist in identifying winning stock picks based on various investing styles [9]

Core Viewpoint - Momentum investing focuses on "buying high and selling higher," contrasting with traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Momentum investing can be risky as stocks may lose momentum when their valuations exceed future growth potential [1] - Identifying the right entry point for momentum stocks is challenging, and investors may end up with overvalued shares [1] Group 2: Bargain Momentum Stocks - Investing in bargain stocks that have recently shown price momentum may be a safer strategy [2] - The Zacks Momentum Style Score is useful for identifying strong momentum stocks, while the 'Fast-Paced Momentum at a Bargain' screen helps find attractively priced fast-moving stocks [2] Group 3: Select Medical (SEM) Analysis - Select Medical (SEM) has a four-week price change of 2.5%, indicating growing investor interest [3] - SEM gained 7.8% over the past 12 weeks, demonstrating its ability to deliver positive returns over a longer timeframe [4] - SEM has a beta of 1.3, suggesting it moves 30% more than the market in either direction [4] Group 4: Valuation and Earnings Estimates - SEM has a Momentum Score of B, indicating a favorable time to invest [5] - The stock has a Zacks Rank 2 (Buy) due to upward revisions in earnings estimates, which attract more investors [6] - SEM is trading at a Price-to-Sales ratio of 0.31, meaning investors pay 31 cents for each dollar of sales, indicating a reasonable valuation [6] Group 5: Additional Investment Opportunities - Besides SEM, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen [7] - Zacks offers over 45 Premium Screens to help identify potential winning stock picks based on various investing styles [8]